265 related articles for article (PubMed ID: 30126398)
1. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
Sun Z; Gao W; Cui JT
BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
3. Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.
Li H; Liu Y; Zhou S; Zhou Q; Yang X
BMC Oral Health; 2023 Sep; 23(1):659. PubMed ID: 37697274
[TBL] [Abstract][Full Text] [Related]
4. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
[TBL] [Abstract][Full Text] [Related]
5. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
6. Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis.
Kamiza AB; Kamiza S; Singini MG; Mathew CG
Trop Med Int Health; 2020 Jun; 25(6):666-672. PubMed ID: 32233050
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
8. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
9. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.
Mandal RK; Yadav SS; Panda AK
Tumour Biol; 2014 Sep; 35(9):8607-13. PubMed ID: 24863946
[TBL] [Abstract][Full Text] [Related]
10. Impact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma risk.
Xie JL; Yang JL; Liu DS; Xie YG; Ji P
Cell Biochem Biophys; 2015 Mar; 71(2):993-8. PubMed ID: 25323564
[TBL] [Abstract][Full Text] [Related]
11. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
[TBL] [Abstract][Full Text] [Related]
12. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
13. TP 53 polymorphisms and melanoma: A meta-analysis.
He T; Wu J; Chen Y; Zhang J
J Cancer Res Ther; 2015; 11(2):409-14. PubMed ID: 26148609
[TBL] [Abstract][Full Text] [Related]
14. Associations between the codon 72 polymorphism of the TP53 gene and the risk of recurrent implantation failure.
Feng Y; Wu YY; Lin XJ; Yang L; Luo ZJ; Zhou YH; Chen J; Li N; Lin Z; Zhao X
J Obstet Gynaecol Res; 2016 Feb; 42(2):184-9. PubMed ID: 26555776
[TBL] [Abstract][Full Text] [Related]
15. Association between the rs1042522 polymorphism in
Fan S; Hao ZY; Zhang M; Liang CZ
Chronic Dis Transl Med; 2017 Jun; 3(2):95-104. PubMed ID: 29063062
[TBL] [Abstract][Full Text] [Related]
16. Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population.
Yang J; Zhu JM; Wu S; Li J; Wang MR; Wang TT; Lu YW
Rheumatol Int; 2017 Apr; 37(4):523-529. PubMed ID: 28184992
[TBL] [Abstract][Full Text] [Related]
17. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
18. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
[TBL] [Abstract][Full Text] [Related]
19. Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.
Hussain SR; Ahmad MK; Mahdi AA; Naqvi H; Ahmad MW; Srivastava S; Nigam K; Gupta S
J Genet; 2016 Jun; 95(2):249-55. PubMed ID: 27350666
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase pi 1 variant and squamous cell carcinoma susceptibility: a meta-analysis of 52 case-control studies.
Wang S; Zhang J; Jun F; Bai Z
BMC Med Genet; 2019 Jan; 20(1):22. PubMed ID: 30665373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]